Delivery Order SPE2DB22D3016-SPE2DB24FAYX0

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,301.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a period of performance through March 10, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,974.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a period of performance through February 2025. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, worth up to $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $1,013.00, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, to support the healthcare needs of the U.S. military and federal government. The contract has a firm fixed-price pricing type and an ultimate completion date of August 30, 2024. This award is a delivery order under a larger...
This federal contract award, valued at $3,194.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply the product "PROCTOFOAM-HC 1%-1% FOAM 10GM" with an ultimate completion date of April 30, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, with a ceiling value of $2,437.37, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The firm-fixed-price delivery order, valued at $2,617.68, has an ultimate completion date of February 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of Proctofoam-HC 1%-1% foam in 10-gram units, with a ceiling value of $1,013.00 and a period of performance through April 23, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type. The award is...
This federal contract award, valued at $1,676.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of March 21, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, valued at $2,062.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, to support federal government healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,511.94, is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAYX0
    Delivery Order

This federal contract award, valued at $1,078.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division on June 20, 2024. The contract is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM, a pharmaceutical product, with a completion date of June 21, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support the U.S. Armed Forces and other government agencies. This contract award does not have a set-aside designation.

Generated 9/19/24, 9:42 AM